Evidence map›Paper›PMID 33472895›Full record

ArticleGut2021

SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting.

Corey A Siegel, Gil Y Melmed, Dermot Pb McGovern, Victoria Rai, Florian Krammer, David T Rubin, Maria T Abreu, Marla C Dubinsky, International Organization for the Study of Inflammatory Bowel Disease (IOIBD), International Organization for the Study of Inflammatory Bowel Diseases (IOIBD)

Open access · hybridAbstract readConsensus Statement
In one paragraph

Article in Gut, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 106 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed, 6 pooled it
11.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 6 syntheses or guidelines pooled it, 184 citations in OpenAlex.

  1. Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systematic review and meta-analysis.Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2022
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Turkish IBD Organization's Position Statement on Inflammatory Bowel Disease Management Recommendations During COVID-19 Pandemic.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2021
    Guideline
  6. Pooled it
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Observational

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Corey A SiegelInflammatory Bowel Disease Center, Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA corey.a.siegel@hitchcock.org.ORCID http://orcid.org/0000-0002-2240-6605
Gil Y MelmedF Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars Sinai Medical Center, Los Angeles, California, USA.
Dermot Pb McGovernF Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars Sinai Medical Center, Los Angeles, California, USA.
Victoria RaiUniversity of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois, USA.
Florian KrammerDepartment of Microbiology, Icahn School of Medicine, Mount Sinai, New York, New York, USA.
David T RubinUniversity of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois, USA.ORCID http://orcid.org/0000-0001-5647-1723
Maria T AbreuDepartment of Medicine, Division of Gastroenterology, Crohn's and Colitis Center, University of Miami Miller School of Medicine, Miami, Florida, USA.
Marla C DubinskyDepartment of Pediatrics, Susan and Leonard Feinstein IBD Center, Icahn School of Medicine, Mount Sinai, New York, New York, USA.ORCID http://orcid.org/0000-0003-4968-5795
International Organization for the Study of Inflammatory Bowel Disease (IOIBD)
International Organization for the Study of Inflammatory Bowel Diseases (IOIBD)
Cedars-Sinai Medical Center · USDartmouth–Hitchcock Medical Center · USIcahn School of Medicine at Mount Sinai · USUniversity of Chicago · USUniversity of Miami · USYale University · US

Funding

ULTRASTRUCTURE AND CYTOMORPHOLOGY COREP30DK042086 · NIDDK · UNIVERSITY OF CHICAGO · PI LIU, CAMBRIAN YANGSHAO · 1990 to 2025
$29.8M
NIDDK NIH HHS P30 DK042086
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19COVID-19 VaccinesInflammatory Bowel DiseasesVaccinationAnti-Inflammatory AgentsConsensusGastroenterologyHumansImmunogenicity, VaccineImmunomodulationInternational CooperationSARS-CoV-2Anti-Inflammatory AgentsCOVID-19 VaccinesCOVID-19crohn's diseaseIBDimmune responseulcerative colitis

Identifiers

PMID33472895
PMCPMC7818789
OpenAlexW3125034838

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.